Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial

Kayo Horibe, Hiroshi Maegawa, Itsuko Miyazawa et al.|Diabetes Research and Clinical Practice|2022

Cited by 27